Les Barons de la Bourse

Emmanuelle Coutanceau

Age : 41

Principales sociétés :

Synthèse

Currently, Emmanuelle Coutanceau is Investment Director at Auriga Partners SA and Partner at Novo Seeds. Dr. Coutanceau is also Partner at Novo Holdings An and on the board of 7 other companies.

In the past Dr. Coutanceau occupied the position of Chairman of Draupnir Bio ApS and Investment Manager at Omnes Capital SAS.

Dr. Coutanceau received a doctorate from Université Paris Diderot-Paris 7, a graduate degree from ESCP Europe Campus Paris and an undergraduate degree from Agrocampus Rennes.

Postes et responsabilités de Emmanuelle Coutanceau

Nom	Titre	Depuis
IO Biotech, Inc. (Recherche biotechnologique et médicale)	Independent Director	2019
Auriga Partners SA	Investment Director	2014
Minervax ApS	Director	-
Pcovery ApS	Director	-
CorWave SA	Director	-
Inthera Bioscience AG	Member-Supervisory Board	-
HepaRegeniX GmbH	Director	-
Antag Therapeutics ApS	Director	-
Novo Holdings A/S	Partner	2018
Novo Seeds	Partner	2018

Emmanuelle Coutanceau: Réseau personnel

Nom	Sociétés liées
Jack Bech Nielsen	IO Biotech, Inc. Novo Holdings A/S
Søren Møller	Novo Seeds Novo Holdings A/S
Mai-Britt Zocca	IO Biotech, Inc.
Kathleen Sereda Glaub	IO Biotech, Inc.
Christian Ellebæk Elling	IO Biotech, Inc.
Priyanka Belawat	IO Biotech, Inc.
Claus Asbjørn Andersson	IO Biotech, Inc.
Brian Burkavage	IO Biotech, Inc.
Andrew Willis	IO Biotech, Inc.
Eva Ehrnrooth	IO Biotech, Inc.